Loading...
Loading...
ISO| Name | Value |
|---|---|
| Revenues | 3.4M |
| Cost of Revenue | 11.2M |
| Gross Profit | -7.8M |
| Operating Expense | 23.9M |
| Operating I/L | -31.8M |
| Other Income/Expense | -1.4M |
| Interest Income | 0.0M |
| Pretax | -33.2M |
| Income Tax Expense | 1.5M |
| Net Income/Loss | -34.7M |
IsoPlexis Corporation is a life sciences company that provides single cell proteomics platform solutions for the development of curative medicines and personalized therapeutics. The company offers IsoLight and IsoSpark instruments, IsoCode and CodePlex chips, and IsoSpeak software, enabling the visualization of protein function at an individual cellular level. Their products provide an end-to-end solution for single cell functional proteomics and multiplexed solutions for ultra-low volume bulk samples. Additionally, they offer research support, services, and post-warranty services to their customers.
